Exosome-delivered pepDCBLD2 promotes glucose metabolism to induce chemoresistance in colon cancer
Abstract Background Oxaliplatin is a standard treatment for colon cancer, but chemoresistance is a considerable challenge. Dysregulation of circRNAs is involved in cancer and translatomics has found that some circRNAs encode polypeptides. Methods Ribosome footprint profiling combined with circRNA se...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-08-01
|
| Edice: | Journal of Translational Medicine |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12967-026-08876-7 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|